Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DNTH

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DNTH
DateTimeSourceHeadlineSymbolCompany
03/11/20254:01PMGlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
03/05/20257:00AMGlobeNewswire Inc.Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of DirectorsNASDAQ:DNTHDianthus Therapeutics Inc
02/26/20257:00AMGlobeNewswire Inc.Dianthus Therapeutics to Participate in Two Upcoming Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
01/30/20257:00AMGlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentations at Two Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
01/08/20257:00AMGlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
11/07/20244:01PMGlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
11/04/20247:00AMGlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
10/15/20247:00AMGlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
09/04/20247:00AMGlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:DNTHDianthus Therapeutics Inc
08/08/20244:01PMGlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
06/28/202411:30AMGlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)NASDAQ:DNTHDianthus Therapeutics Inc
06/12/20247:00AMGlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
05/30/20244:30PMGlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
05/09/20244:01PMGlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
05/08/20244:30PMGlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
05/03/20244:30PMGlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
04/11/20247:30AMGlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
04/05/20244:30PMGlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
03/21/20244:01PMGlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
03/07/20244:30PMGlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
02/26/20247:00AMGlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DNTH